Furthermore, there was an increasing trend in the proportion of trunk osteoarticular involvement with advancing age ( P < 0.001).
← all phrases
“an increasing trend”
Sighted at
p<0.09
In the literature
Both these scores showed an increasing trend with respect to the academic year ( P < 0.001).
The detection rate of PCLs was 0.2% [n/N=3/1,828, Boot strapping bias-corrected and accelerated (BCa) 95% CI 0.1-0.3%] for a total score of 0 points, 0.5% (n/N=12/2,278, BCa 95% CI 0.3-0.8%) for 1.0 point, 1.3% (n/N=5/386, BCa 95% CI 0.8-1.9%) for 1.5 points, 0.8% (n/N=14/1,752, BCa 95% CI 0.5-1.1%) for 2.0 points, 1.6% (n/N=21/1,274, BCa 95% CI 1.1-2.2%) for 2.5 points, 2.1% (n/N=10/476, BCa 95% CI 1.1-3.2%) for 3.0 points, 3.3% (n/N=34/1,020, BCa 95% CI 2.4-4.6%) for 3.5 points, and 5.4% (n/N=19/355, 3.4-7.6%) for ≥4.0 points, showing an increasing trend with the total score of the scoring system (Cochran-Armitage test, p<0.001) ( Table 4 , Fig. 4 ).
In the participants aged under 60 years old, an increasing trend was found in WCCI ( p value for trend: <0.001) and reach a maximum of 1.2 (95% CI, [0.7, 1.8], p < 0.001; Fig. 3b ; Supplementary Table 3 ) when taking training for 6 days per week.
In addition, the tissue enzyme level of SRD5α2 exhibited an increasing trend ( P < 0.001), and the nuclear factor NF-κB p65 and the transforming growth factor TGF-β also showed a significant upward trend ( P < 0.001). 3.2 Metabolomics study 3.2.1 Metabolic profile analysis Metabolomic studies were conducted using the UHPLC-Q-Orbitrap HRMS technique.
Underweight women had the lowest change in AC (delta AC) with an increasing trend observed as BMI increased ( P =0.001).
This demonstrated an increasing trend with increasing SMN2 copy numbers ( F = 33.350, p < 0.001) ( Figure 4B ).
In trend analysis by ethnicities, among patients <50 years old, there was an increasing trend in Caucasians (63.9% versus 67.9%; p < 0.001) and Asian females (58.4% versus 62.6%; p < 0.001).
In an M–K trend analysis, we identified an increasing trend of cumulative rCFR for the week first to 17th ( P < 0.001 and tau = 0.93).
Variables such as age, weight, RBC count, hemoglobin, hematocrit, albumin, PCO2, PO2, and pH showed a decreasing trend with increasing LAR ( P < 0.001), while WBC count, RDW, creatinine, BUN, ALT, AST, potassium, glucose, INR, PT, PTT, and lactate demonstrated an increasing trend with higher LAR quartiles (all P < 0.001).
In the FK group, the expression of miR-21-5p in serum, tear fluid, and corneal tissue showed an increasing trend (Fig. 1 D, P < 0.001).
A total of 576 cases were identified, corresponding to an incidence of 5.08 per 100,000 inhabitants, with an increasing trend ( p < 0.001).
In females, an increasing trend was observed across all age groups, particularly in those aged 45 years or younger (APC: 3.20, 95% CI: 2.72 to 3.66, p < 0.001) (Table S1 ).
Moreover, ‘DRG payment cases’ performed an insignificant reduction in readmission rate, whereas FFS reversion cases exhibited an increasing trend (1.49%, P < 0.001) (Fig. 2 ).
3B , the ACD illustrated an increasing trend with the observation period among all groups in contralateral eyes (Friedman test, P < 0.001).
Additionally, over the nine years, an increasing trend was explicitly observed for brain cancer (p < 0.001), while the trends for other cancers remained stable.
Similarly, GPP max_EC-LUE also followed the same pattern with NDVI max , showing an increasing trend from 1982 to 2018 at a rate of 1.13 ± 0.12 × 10 −2 g C m −2 d −1 yr −1 (t (35) = 9.67, P < 0.001, 95% CI [0.89 × 10 −2 , 1.36 × 10 −2 ]), but declining during the 1998-2009 period at a rate of −0.51 ± 0.29 × 10 −2 g C m −2 d −1 yr −1 (t (10) = −1.77, P = 0.11, 95% CI [−1.14 × 10 −2 , 0.13 × 10 −2 ], Supplementary Fig. 2c ).
Concurrently, UACR demonstrated an increasing trend in albuminuria across the quartiles (p < 0.001).
Moreover, at T35, pRBC bags showed significantly higher mean values than WB ( P = .03), particularly due to an increasing trend over time of nLR pRBC ( P < .001).
The overall prevalence (per 100,000 persons) also showed an increasing trend, from 3065.76 (95% CI: 3051.68–3079.88) to 6296.38 (95% CI: 6277.02–6315.78), with an AAPC of 6.69% (95% CI: 6.45–7.03; p < 0.001) ( Fig. 1 a, Table 3 , Supplementary Table S2 ).
For all undesirable outcomes, preintervention there was an increasing trend of 1.8% (β = 0.018; 95% CI: 0.013 to 0.024; p < 0.001), an immediate 14.4% decrease after the intervention (β = − 0.144; 95% CI: − 0.255 to − 0.033; p = 0.012), and a decreasing trend of 1.8% through the postintervention period (β = − 0.018; 95% CI: − 0.026 to − 0.009; p < 0.001).
The variables “family history of cancer” (p<0.001), “alcoholism” (p<0.001), “smoking” (p<0.001), “TNM staging” (p<0.001) had a decreasing trend, while “clinical start of treatment” (p<0.001), “origin” (p=0.008) and “occupation” (p<0.001) indicated an increasing trend.
The MP‐NN score showed an increasing trend from HC to LUAD, with significantly higher scores in patients with LUAD than those in HC and LBD ( p < 0.001, Figure 2B ).
Additionally, f in each anatomical compartment of IOCM group reached the lowest value at 48-h ( p < 0.001, p = 0.039, and p = 0.001, respectively) and showed an increasing trend at 72-h ( p < 0.001, p = 0.010, and p = 0.113, respectively).
ovale cases showed an increasing trend (χ2 = 13.690, P < 0.001), peaking in 2021 at 44.44% (Fig. 1 ).